Invention Grant
- Patent Title: Sustained-release preparation of ivabradine or pharmaceutically acceptable salts thereof
- Patent Title (中): 伊伐布雷定或其药学上可接受的盐的缓释制剂
-
Application No.: US14235858Application Date: 2012-06-18
-
Publication No.: US09283189B2Publication Date: 2016-03-15
- Inventor: Kai Liu , Yuxia Wu
- Applicant: Kai Liu , Yuxia Wu
- Applicant Address: CN Lianyungang, Jiangsu
- Assignee: Jiangsu Hengrui Medicine Co., Ltd.
- Current Assignee: Jiangsu Hengrui Medicine Co., Ltd.
- Current Assignee Address: CN Lianyungang, Jiangsu
- Agency: Panitch Schwarze Belisario & Nadel LLP
- Priority: CN201110228902 20110805
- International Application: PCT/CN2012/077079 WO 20120618
- International Announcement: WO2013/020416 WO 20130214
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K31/55 ; B29C43/00
Abstract:
Disclosed is a sustained-release preparation of ivabradine or pharmaceutically acceptable salts thereof. The preparation contains ivabradine or pharmaceutically acceptable salts thereof and a sustained-release framework material, wherein the sustained-release framework material is selected from polyoxyethylene, or a mixture of polyoxyethylene and polyvinyl acetate or polyvinyl pyrrolidone.
Public/Granted literature
- US20140179683A1 SUSTAINED-RELEASE PREPARATION OF IVABRADINE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF Public/Granted day:2014-06-26
Information query
